Our histological evaluation of vascular lesions and the measurement of serum cytokine/chemokine levels in the mouse KD model revealed that anti-ApoA2 treatment suppressed the development of coronary arteritis in a mouse model of KD vasculitis in a dose-dependent manner. The gene discussed is APOA2; the disease is vasculitis.